C1 inhibitor deficiency: 2014 United Kingdom consensus document

E-ISSN： 1365-2249|180|3|475-483

ISSN： 0009-9104

Source： CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol.180, Iss.3, 2015-06, pp. : 475-483

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ecallantide for the treatment of acute attacks of hereditary angioedema due to C1-inhibitor deficiency

By Bernstein Jonathan A Biedenkapp Joseph

Clinical Investigation, Vol. 3, Iss. 9, 2013-09 ,pp. : 859-873

Future Science

Access to resources Recommend Favorite

Efficacy of on‐demand treatment in reducing morbidity in patients with hereditary angioedema due to C1 inhibitor deficiency

ALLERGY, Vol. 70, Iss. 12, 2015-12 ,pp. : 1553-1558

John Wiley & Sons Inc

Access to resources Recommend Favorite

The 2000 United Kingdom Haemophilia Centre Doctors’ Organisation (UKHCDO) Inhibitor Guidelines

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 1, 2002-05 ,pp. : 19-21

Karger

Access to resources Recommend Favorite

The use of ezetimibe in achieving low density lipoprotein lowering goals in clinical practice: position statement of a United Kingdom consensus panel

By Mikhailidis D. P. Wierzbicki A. S. Daskalopoulou S. S. Al-Saady N. Griffiths H. Hamilton G. Monkman D. Patel V. Pittard J. Schachter M.

Current Medical Research and Opinion, Vol. 21, Iss. 6, 2005-06 ,pp. : 959-970

Informa Healthcare

Access to resources Recommend Favorite

Hereditary and Acquired Complement Component 1 Esterase Inhibitor Deficiency: A Review for the Hematologist

Acta Haematologica, Vol. 127, Iss. 4, 2012-03 ,pp. : 208-220

Karger

Access to resources Recommend Favorite